FAP and Hepatic fibrosis: Although we demonstrated the antifibrotic efficacy of PRL in a liver fibrosis model, the selective activation of PRL by FAP suggests the potential of PRL for the treatment of various fibrotic diseases in which FAP is overexpressed.